GraMedica is a global medical device company and a leader in new product development and medical education in orthopedics. Founded in 2003, the company is focused on providing innovative foot care solutions that address the root problem rather than just treating the symptoms. Its flagship products include the HyProCure TaloTarsal Stabilization device, the osteo-WEDGE Open Wedge Bone Locking system, and the Soleus Foot Care Collection.
One of the company's key initiatives is to raise awareness about talotarsal displacement, a commonly undiagnosed condition with far-reaching implications. By offering educational programs through its sister organization, the Graham International Implant Institute (GIII), GraMedica focuses on equipping foot and ankle surgeons with real treatment solutions for optimal patient outcomes.
With its headquarters in the United States, GraMedica oversees research, production, and worldwide support for its products. As the company continues to expand its product lines, it remains committed to its mission of "Changing lives, one step at a time."
There is no investment information
No recent news or press coverage available for GraMedica.